The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Microbiome in Pediatric Rheumatic Diseases

The Microbiome in Pediatric Rheumatic Diseases

April 15, 2016 • By Matthew Stoll, MD, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Monkey Business Images/shutterstock.com

Monkey Business Images/shutterstock.com

The human intestinal microbiota is home to more than 1,000 bacterial species, containing approximately 3 million genes, many of which code for functions that have the potential to affect human physiology.1 Smaller numbers of organisms are also present in the skin, upper gastrointestinal tract, female reproductive tract and the oro- and nasopharynx. As tools have been developed in the past 10–15 years to query the microbiota, an enormous body of literature addressing the impact of the microbiota on a variety of chronic illnesses has emerged.

You Might Also Like
  • Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease
  • Microbiome Research Provides Clue to Rheumatoid Arthritis
  • The Microbiome’s Role in Inflammatory Arthritis
Explore This Issue
April 2016

One particular condition that has been the subject of recent studies is juvenile idiopathic arthritis (JIA). Our group at the University of Alabama at Birmingham was the first to look at the microbiome in JIA, focusing exclusively on pediatric subjects with enthesitis-related arthritis (ERA, the pediatric version of spondyloarthritis), a condition with known genetic and clinical links to inflammatory bowel disease (IBD).2

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

We reported decreased fecal abundance of Faecalibacterium prausnitzii, a species with potential anti-inflammatory properties that also appears to be deficient in IBD patients.3,4 Additionally, a subset of patients was identified with a markedly increased abundance of the Bacteroides genus.

The same genus was also shown to be elevated in a Finnish study of children with JIA, mostly with oligo-articular and poly-articular presentations; however, that study did not identify differences in the abundance of F. prausnitzii.5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

These studies raise the possibility that some bacteria serve to promote arthritis in children, or even subsets of children, and others play a protective role.

Are There Good & Bad Microbiota?

These studies raise the possibility that there are some beneficial and some not-so-beneficial organisms. This is not a new hypothesis. The concept behind the hygiene hypothesis holds that alterations in the microbiota associated with modernization have resulted in an increased incidence of a variety of immune diseases, such as atopy and IBD.6

Although few would be nostalgic for high perinatal and childhood mortality, the notion that pre-industrialization microbiota may have something to offer us has gained traction. Along those lines, De Filippo et al compared the intestinal microbiota of young children, aged 2–6, in Florence, Italy, with those in a rural village in Burkina Faso, West Africa, a region characterized by an agrarian lifestyle and carbohydrate- and fiber-rich diets.7 There, they found substantial alterations in the intestinal micro­biota (see Table 1), including a striking expansion of the Prevotella genus in the Burkina Faso children, with this genus constituting over 50% of the microbiota, while being virtually undetectable in the Florence children. Additional differences included decreases in some potential pathogenic genera and increased microbial diversity observed in the Burkino Faso population. The authors argued that the totality of these findings indicated that the Burkina Faso children likely had a microbiota that could protect them against pathogens, as well as against inflammatory gastrointestinal diseases. It is, however, important to note that there are many differences aside from diet in these two highly diverse populations of children.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 8 | Single Page

Filed Under: Conditions Tagged With: gastrointestinal disease, juvenile rheumatoid arthritis, Microbiome, microbiotia, Pediatric, Research, Rheumatic DiseaseIssue: April 2016

You Might Also Like:
  • Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease
  • Microbiome Research Provides Clue to Rheumatoid Arthritis
  • The Microbiome’s Role in Inflammatory Arthritis
  • Fecal Metabolomics Implicate Tryptophan Pathway in Pediatric Spondyloarthritis

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.